Prague (ots/PRNewswire) - Zentiva is a major developer and producer of high-quality and affordable medicines in Europe. Zentiva will donate 100,000 packs of medicines to humanitarian aid programs targeted at helping the citizens of Ukraine. The medicines will include life-saving hospital medicines, cardiovascular medicines, pain medication, and anti-infectives. The ...
Lisbon, Portugal (ots/PRNewswire) - Hovione today announced that the Board of Directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione's Chief Executive Officer, effective 1st April 2022. Guy Villax, who has been Hovione's CEO for the past 25 years will now serve as a Member of the Board and shareholder. During his tenure, Hovione grew tenfold. The company currently employs 2000 ...
Lisbon (ots/PRNewswire) - Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform. Zerion´s innovative Dispersome® technology builds on a new ...
New York (ots/PRNewswire) - The approval will aid European healthcare providers in clinically assessing lung sound data to determine whether wheezing is detected TytoCare, the global health care industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, ...
Boston, Reykjavik, Iceland and Berlin (ots/PRNewswire) - - UnitedHealth Group and Anthem veteran Pamela Stahl joins as Chief Commercial Officer (CCO) and President, North America to lead Sidekick's global commercial strategy, driving revenue growth with international pharmaceutical majors and U.S.-based payers. - Mitchell Mudra joins Sidekick from UnitedHealth Group as ...
Nes Ziona, Israel and Shanghai, China (ots/PRNewswire) - Intradermal COVID vaccination studies are emerging in a global effort to multiply available doses by harnessing skin immunity to reduce dosage required for effective vaccination. In a hallmark study published recently by IMB scientists[1], subjects were ...
Vienna / Baar (ots) - Scientists from the Swiss-Austrian research group HealthBiocare GmbH and System Biologie AG, in collaboration with the University of Vienna, have found a new non-invasive approach for the detection of the nine most common types of cancer. Although cancer is a leading cause of death worldwide, there are still no clinically approved tests for broader cancer screening of the population. The earlier ...
Lausanne, Switzerland and Durban, South Africa (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership to launch Trelstar® (Triptorelin) in South Africa for the treatment of locally advanced and metastatic hormone dependent prostate ...
Harrow, England (ots/PRNewswire) - Sondelbay – is a self-administered, once-a-day subcutaneous injection for patients with osteoporosis using a pen device - Accord's fourth biosimilar, joins the company's established portfolio across Europe, and marks its first branded product in a new Bone Health franchise representing another great milestone in Accord's growing ...
Nes Ziona, Israel (ots/PRNewswire) - Intradermal COVID-19 vaccination studies are emerging in a global effort to use available doses more effectively by harnessing skin immunity to reduce the dosage required for effective vaccination, as well as to improve the immunogenicity of weaker vaccines. Additionally, there ...
Tübingen (ots) - Acousia Therapeutics GmbH – along with its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University of Tübingen) and Synovo GmbH (Tübingen) – will be presenting data on the the company’s ...
Lyon, France (ots/PRNewswire) - genOway, a world leader in the field of genetically modified innovative research models, announced today that it has granted a non-exclusive CRISPR/Cas9 license to the most important funding institution of biomedical academic research in the United Kingdom. In December 2018, genOway ...
Prague (ots/PRNewswire) - The Top Employee Institute has certified Zentiva as a Top Employer. This prestigious award was received for Zentiva's exceptional standards across 6 Human Resources-domains in its home countries the Czech Republic and Romania. The assessment was covering 20 topics including People Strategy, Work Environment, Talent Acquisition, Learning, Well-being, Diversity & Inclusion, and many more. "I am ...
Paris (ots/PRNewswire) - - Consolidated revenue of €4.725 billion, up +4.3% at constant rates (+0.8% at current rates) - Revenue for brand-name medicines of €3.306 billion +4.8% at constant rates (+0.6% at current rates) and €1.419 billion for the generics +2.9% at constant rates (+1.1% at current rates) - An accelerated oncology strategy with the acquisition of ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - Some research relies almost entirely on animal models. An example is the SNSF-funded project on virus surveillance in the mouse brain. "The immune system has a place where it is born, a place where it is educated and a place where it goes to work." Natalia Pikor, research group leader at St. Gallen cantonal hospital, is studying one of the most complicated systems in the bodies of vertebrate animals and ...
Tel Aviv, Israel (ots/PRNewswire) - DALI Medical Devices, an innovative developer and distributor of drug delivery devices, today announced the first commercial implementation of its SAN-Light passive safety needle. SAN-Light was chosen to be used with ADVANZ PHARMA's MYTOLAC®/MYRELEZ® - the first generic ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - In an SNSF-funded project, researchers are studying how bacteria infect the lungs. They are developing an alternative to animal testing that complements existing methods. When bacteria enter our lungs or live in our guts, they physically interact with our own cells that line the openings of our body like a protective layer. Some bacteria help us digest, others make us sick. Alexandre Persat from EPF Lausanne ...
Lausanne, Switzerland - San Francisco (ots) - Funding to support BIOiSIMTM computational platform to reduce the need for animal testing by selecting compounds showing promise to cure a disease prior to research in humans Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today their co-investment in California-based start-up VeriSIM Life’s ...
San Francisco, CA (ots) - Financing led by Morpheus Ventures supports further revenue growth for the company’s next-generation AI platform, redefining the preclinical translational drug development landscape by accurately predicting and accelerating clinical outcomes VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - A study funded by the Swiss National Science Foundation shows that the link between sleep behaviour and intestinal flora is already present in infancy. The gut flora of infants is connected to their sleep patterns. This effect is evident from the age of three months, as sleep researchers Salome Kurth of the University of Fribourg and Sarah Schoch of the University of Zurich have now shown. For example, ...
Heidelberg, Germany and Cambridge, Mass (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced key results of the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investigational drug ...
Oxford, England (ots/PRNewswire) - OrganOx, a world leader in normothermic machine perfusion (NMP), today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its metra system. The OrganOx metra is a fully automated NMP device for the preservation and transport of donor livers destined for transplantation. The marketing ...
Heidelberg, Germany, and Cambridge, Mass. (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today provided a development update on the phase 3 trial of SHR8058 eye drops (perfluorohexyloctane) for the ...
London (ots/PRNewswire) - - Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery platform and experimentally validated by AstraZeneca - Announcement represents the second collaboration milestone following the addition of a novel chronic kidney disease target to ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - An interdisciplinary team funded by the Swiss National Science Foundation shows that the R number of coronavirus can be estimated quickly and cost-effectively from wastewater. Since the start of the coronavirus (Sars-Cov-2) pandemic, many public health measures have been decided based on its dynamic of spread, more precisely, on the reproductive number of the virus, known as the R number. This value indicates ...
Bologna, Italy and Huntingdon Valley, Pa. (ots/PRNewswire) - Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - Projects taking part in the National Research Programme "Covid-19" (NRP 78) of the Swiss National Science Foundation (SNSF) are pursuing highly promising approaches in a drive to develop new vaccines. Three research groups have adopted interesting approaches to the highly topical issue of vaccines. The team led by Steve Pascolo is investigating ways of improving functionality and stability of mRNA vaccines, ...
Copenhagen, Denmark (ots/PRNewswire) - - Results from ALK-sponsored REACT (REAl-world effeCTtiveness of allergy immunotherapy) study have been published in The Lancet Regional Health - Europe - REACT demonstrated the real-world effectiveness of allergy immunotherapy (AIT) - including ALK products - in allergic ...